Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2021 Volume 22 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article

Role of CXCL12, TP53 and CYP1A1 gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia

  • Authors:
    • Eleni Kampouraki
    • Marilena Lourou
    • Maria I. Zervou
    • Evangelia-Dimitra Ampazoglou
    • Emmanuel Yachnakis
    • Nikolaos Katzilakis
    • George N. Goulielmos
    • Eftichia Stiakaki
  • View Affiliations / Copyright

    Affiliations: Department of Pediatric Hematology‑Oncology, University Hospital of Heraklion and Laboratory of Blood Diseases and Childhood Cancer Biology, Medical School, University of Crete, 71003 Heraklion, Greece, Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, Medical School of Crete, University of Crete, 71003 Heraklion, Greece, Laboratory of Bio-Medical Data Analyses, Digital Applications and Interdisciplinary Approaches, University of Crete, 71003 Heraklion, Greece
  • Article Number: 659
    |
    Published online on: July 13, 2021
       https://doi.org/10.3892/ol.2021.12920
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute lymphoblastic leukemia (ALL) is the most common type of childhood leukemia and represents one third of all pediatric malignancies. Epidemiological studies have shown that various genetic factors play a crucial role in leukemogenesis. Recent genetic association studies on cancer risk have focused on the effects of single‑nucleotide polymorphisms (SNPs) in genes that regulate inflammation and tumor suppression, such as chemokines, TP53 and cytochrome P450s (CYPs). Genetic polymorphisms in the 3' untranslated region of the C‑X‑C motif chemokine ligand 12 (CXCL12; rs1801157) and TP53 (rs1042522) genes have been suggested to influence the risk of ALL in children, while other studies have indicated an association between the CYP1 subfamily A member 1 (CYP1A1)*2C (rs1048943) allele and leukemia risk. The aim of the present study was to investigate the possible association of rs1801157 (CXCL12), rs1042522 (TP53) and rs1048943 (CYP1A1*2C) SNPs with an increased susceptibility of developing ALL. These SNPs were analyzed in 86 children or adolescent patients with ALL and 125 control subjects by PCR‑restriction fragment length polymorphism and allelic‑specific chain reaction techniques. A higher frequency of CYP1A1*2C heterozygotes and TP53 rare homozygotes, which include the proline (Pro)/Pro genotype, was observed among children with ALL and control subjects, whereas no significant differences were observed for the CXCL12 SNP. Furthermore, the analysis of various allelic combinations of the aforementioned gene polymorphisms demonstrated a markedly increased risk of developing ALL in children. In conclusion, the present study demonstrated that there was a strong association between CYP1A1*2C heterozygotes, as well as the TP53 Pro/Pro genotype, and an increased susceptibility for pediatric ALL in Caucasians.
View Figures
View References

1 

Belson M, Kingsley B and Holmes A: Risk factors for acute leukemia in children: A review. Environ Health Perspect. 115:138–145. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Tasian SK and Hunger SP: Genomic characterization of paediatric acute lymphoblastic leukaemia: An opportunity for precision medicine therapeutics. Br J Haematol. 176:867–882. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Hunger SP and Mullighan CG: Acute Lymphoblastic Leukemia in Children. N Engl J Med. 373:1541–1552. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Mavrea K, Efthymiou V, Katsibardi K, Tsarouhas K, Kanaka-Gantenbein C, Spandidos DA, Chrousos G, Kattamis A and Bacopoulou F: Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: A meta-analysis. Oncol Lett. 21:2622021. View Article : Google Scholar : PubMed/NCBI

5 

Pui CH: Precision medicine in acute lymphoblastic leukemia. Front Med. 14:689–700. 2020. View Article : Google Scholar : PubMed/NCBI

6 

Iacobucci I and Mullighan CG: Genetic basis of acute lymphoblastic leukemia. J Clin Oncol. 35:975–983. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Sweet-Cordero EA and Biegel JA: The genomic landscape of pediatric cancers: Implications for diagnosis and treatment. Science. 363:1170–1175. 2019. View Article : Google Scholar : PubMed/NCBI

8 

Vijayakrishnan J and Houlston RS: Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Haematologica. 95:1405–1414. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Kampouraki E, Goulielmos GN and Stiakaki E: Understanding the role of genetics in childhood acute lymphoblastic leukemia (Review). World Acad Sci J. Jun 16–2020.(Epub ahead of print). View Article : Google Scholar

10 

Mishra P, Banerjee D and Ben-Baruch A: Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol. 89:31–39. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001. View Article : Google Scholar

12 

de Lourdes Perim A, Guembarovski RL, Oda JM, Lopes LF, Ariza CB, Amarante MK, Fungaro MH, de Oliveira KB and Watanabe MA: CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL). Mol Biol Rep. 40:4591–4596. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Costa KA and Guillo LA: TP53 codon 72 polymorphism in pigmentary phenotypes. J Biosci. 37:33–39. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Moskovits N, Kalinkovich A, Bar J, Lapidot T and Oren M: p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res. 66:10671–10676. 2006. View Article : Google Scholar : PubMed/NCBI

15 

Olivier M, Hollstein M and Hainaut P: TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2:a0010082010. View Article : Google Scholar : PubMed/NCBI

16 

Elfaki I, Mir R, Almutairi FM and Duhier FM: Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis. Asian Pac J Cancer Prev. 19:2057–2070. 2018.PubMed/NCBI

17 

Han F, Tan Y, Cui W, Dong L and Li W: Novel insights into etiologies of leukemia: A HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk. Am J Epidemiol. 178:493–507. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Lu J, Zhao Q, Zhai YJ, He HR, Yang LH, Gao F, Zhou RS, Zheng J and Ma XC: Genetic polymorphisms of CYP1A1 and risk of leukemia: A meta-analysis. OncoTargets Ther. 8:2883–2902. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Docea AO, Vassilopoulou L, Fragou D, Arsene AL, Fenga C, Kovatsi L, Petrakis D, Rakitskii VN, Nosyrev AE, Izotov BN, et al: CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides. Toxicol Rep. 4:335–341. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Hoidy WH, Jaber FA and Al-Askari MA: Association of CYP1A1 rs1048943 polymorphism with prostate cancer in Iraqi men patients. Asian Pac J Cancer Prev. 20:3839–3842. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Li S, Li G, Kong F, Liu Z, Li N, Li Y and Guo X: The association of CYP1A1 gene with cervical cancer and additional SNP-SNP interaction in Chinese women. J Clin Lab Anal. 30:1220–1225. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Razmkhah F, Pazhakh V, Zaker F, Atashrazm F and Sheikhi M: Frequency of CYP1A1*2C polymorphism in patients with leukemia in the Iranian population. Lab Med. 42:220–223. 2011. View Article : Google Scholar

23 

Joseph T, Kusumakumary P, Chacko P, Abraham A and Radhakrishna Pillai M: Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer. 43:560–567. 2004. View Article : Google Scholar : PubMed/NCBI

24 

Swinney RM, Beuten J, Collier AB III, Chen TT, Winick NJ, Pollock BH and Tomlinson GE: Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children. Cancer Epidemiol Biomarkers Prev. 20:1537–1542. 2011. View Article : Google Scholar : PubMed/NCBI

25 

de Jonge R, Tissing WJ, Hooijberg JH, Jansen G, Kaspers GJ, Lindemans J, Peters GJ and Pieters R: Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood. 113:2284–2289. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Asnafi AA, Farshchi N, Khosravi A, Ketabchi N, Behzad MM and Shahrabi S: Significance of genetic polymorphisms in hematological malignancies: Implications of risk factors for prognosis and relapse. Mag Eur Med Oncol. 11:330–344. 2018.

27 

Fujita TC, Sousa-Pereira N, Amarante MK and Watanabe MA: Acute lymphoid leukemia etiopathogenesis. Mol Biol Rep. 48:817–822. 2021. View Article : Google Scholar : PubMed/NCBI

28 

Wang Y, Miller S, Roulston D, Bixby D and Shao L: Genome-wide single-nucleotide polymorphism array analysis improves prognostication of acute lymphoblastic leukemia/lymphoma. J Mol Diagn. 18:595–603. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Vijayakrishnan J, Studd J, Broderick P, Kinnersley B, Holroyd A, Law PJ, Kumar R, Allan JM, Harrison CJ, Moorman AV, et al PRACTICAL Consortium, : Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. Nat Commun. 9:13402018. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kampouraki E, Lourou M, Zervou MI, Ampazoglou E, Yachnakis E, Katzilakis N, Goulielmos GN and Stiakaki E: Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia. Oncol Lett 22: 659, 2021.
APA
Kampouraki, E., Lourou, M., Zervou, M.I., Ampazoglou, E., Yachnakis, E., Katzilakis, N. ... Stiakaki, E. (2021). Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia. Oncology Letters, 22, 659. https://doi.org/10.3892/ol.2021.12920
MLA
Kampouraki, E., Lourou, M., Zervou, M. I., Ampazoglou, E., Yachnakis, E., Katzilakis, N., Goulielmos, G. N., Stiakaki, E."Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia". Oncology Letters 22.3 (2021): 659.
Chicago
Kampouraki, E., Lourou, M., Zervou, M. I., Ampazoglou, E., Yachnakis, E., Katzilakis, N., Goulielmos, G. N., Stiakaki, E."Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia". Oncology Letters 22, no. 3 (2021): 659. https://doi.org/10.3892/ol.2021.12920
Copy and paste a formatted citation
x
Spandidos Publications style
Kampouraki E, Lourou M, Zervou MI, Ampazoglou E, Yachnakis E, Katzilakis N, Goulielmos GN and Stiakaki E: Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia. Oncol Lett 22: 659, 2021.
APA
Kampouraki, E., Lourou, M., Zervou, M.I., Ampazoglou, E., Yachnakis, E., Katzilakis, N. ... Stiakaki, E. (2021). Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia. Oncology Letters, 22, 659. https://doi.org/10.3892/ol.2021.12920
MLA
Kampouraki, E., Lourou, M., Zervou, M. I., Ampazoglou, E., Yachnakis, E., Katzilakis, N., Goulielmos, G. N., Stiakaki, E."Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia". Oncology Letters 22.3 (2021): 659.
Chicago
Kampouraki, E., Lourou, M., Zervou, M. I., Ampazoglou, E., Yachnakis, E., Katzilakis, N., Goulielmos, G. N., Stiakaki, E."Role of <em>CXCL12</em>, <em>TP53</em> and <em>CYP1A1</em> gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia". Oncology Letters 22, no. 3 (2021): 659. https://doi.org/10.3892/ol.2021.12920
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team